Our future studies will further uncover the mechanism(s) by which SIM2 regulates STING under normal developmental conditions as well as in cancer and assess the use of this relationship as a therapeutic benefit in breast cancer treatment options. The gene discussed is SIM2; the disease is breast carcinoma.